| [1] |
Contente S,Kenyon K,Ri moldi D,et al.Expression of gene rrg is associated with reversion of NIH 3T3 transfor med by LTR-c-H-ras.Science,1990,249:796-798.
|
| [2] |
Panchenko MV,Stetler-Stevenson WG,Trubetskoy OV,et al.Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase:potential role of procollagen C-proteinase.J Biol Chem,1996,271:7113-7119.
|
| [3] |
Uzel MI,Scott IC,Babakhanlou-Chase H,et al.Multiple bone morphogenetic protein 1-related mammalian metallo-proteinases process prolysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures.J Biol Chem,2001,276:22537-22544.
|
| [4] |
Tang C,Klin man JP.The catalytic function of bovine lysyl oxidase in the absence of copper.J Biol Chem,2001,276:30575-30578.
|
| [5] |
Rucker RB,Kosonen T,Clegg MS,et al.Cooper,lysyl oxidase,and extracellar matrix protein crosslinking.Am J Clin Nutr,1998,67:966-1002.
|
| [6] |
Jeay S,Pianetti S,Herbert M,et al.Lysyl oxidase inhibits ras-mediated transfor mation by preventing activation of NF-B.Mol Cell Biol,2003,23:2251-2263.
|
| [7] |
Mungo L,Kagan HM.Lysyl oxidase properties regulation and multiple f unctions in biology.Matrix Biol,1998,16:387-398.
|
| [8] |
Molnar J,Fong KS,He QP,et al.Structural and functional diversity of lysyl oxidase and the LOXlike proteins.Biochi m Biophys Acta,2003,1647:220-224.
|
| [9] |
Maki JM,Rasanen J,Tikkanen H,et al.Inactivation of the lysyl oxidase gene LOX leads to aortic aneurys ms cardiovascular dysf unction and perinatal death in mice.Circulation,2002,106:2503-2509.
|
| [10] |
Fong SF,Dietzsch E,Fong KS,et al.Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors.Genes Chromo-somes Cancer,2007,46:644-655.
|
| [11] |
Woznick AR,Braddock AL,Dulai M,et al.Lysyl oxidase expression in bronchogenic carcinoma.Am J Surg,2005,189:297-301.
|
| [12] |
Peyrol S,Raccurt M,Gerard F,et al.Lysyl oxidase gene expression in the stromal reaction toin situ and invasive ductal breast carcinoma.Am J Pathology,1997,150:497-504.
|
| [13] |
Akiri G,Sabo E,Dafni H ,et al.Lysyl oxidase-related protein-1 promotes tu mor fibrosis and tumor progression in vivo.Cancer Res,2003,63:1657-1666.
|
| [14] |
Kirsch mann DA,Seftor EA,Nieva DR,et al.Differentially expressed genes associated with the metastatic phenotypein breast cancer.Cancer.Res,1999,55:127-136.
|
| [15] |
Kirsch mann DA,Seftor EA,Fong SF,et al.A molecular role for lysyl oxidasein breast cancer invasion.Cancer Res,2002,62:4478-4483.
|
| [16] |
Kirsch mann DA,Payne SL,Seftor EA ,et al.Tumor suppressor gene Maspin and hypoxia inversely regulate lysyl oxidase facilitated breast cancer motility.Proc Amer Assoc Cancer Res,2005,46:57-58.
|
| [17] |
Erler JT,Bennewith KL,Nicolau M,et al.Lysyl oxidase is essential for hypoxia-induced metastasis.Nature,2006,440:12222-12226.
|
| [18] |
Payne SL,Fogelgren B,Hess AR,et al.Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.Caner Res,2005,65:11429-11436.
|
| [19] |
Nellaiappan K,Risitano A,Liu G,et al.Fully processed lysyl oxidase catalyst translocates from the extracellular spaceinto nuclei of aortic smooth muscle cells.J Cell Biochem,2000,79:576-582.
|
| [20] |
Payne SL,Angela R.Hess AR,et al.Lysyl oxidase facilitates intracellular signaling in invasive breast cancer cells.Proc Amer Assoc Cancer Res,2005,46:67-68.
|
| [21] |
Palamakumbura AH,Jeay S,Guo Y,et al.The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transfor med cells.J Biol Chem,2004,279:40593-40600.
|
| [22] |
Min C,Kathrin KH,Ying Z,et al.The tu mor suppressor activity of thelysyl oxidase propeptide reverses theinvasive phenotype of Her-2/neu-driven breast cancer.Cancer Res,2007,67:1105-1112.
|
| [23] |
Kly mkowsky MW,Savagner P,Epithelial mesenchy mal transition:a cancer researcher's conceptual friend and foe.Am J Pathol,2009,174:1588-1593.
|
| [24] |
Min C,Ying Z,Siddharth R,et al.Thelysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130cas in breast cancer cells.J Biol Chem,2009,284:1385-1393.
|
| [25] |
Min C,Yu Z,Kirsch KH,et al.A loss-of-f unction poly morphismin the propeptide domain of the LOX gene and breast cancer.Cancer Res,2009,69:6685-6693.
|
| [26] |
Polgar N,Fogelgren B,Csiszar K,et al.Theinteraction of lysyl oxidase with the placental lactogen hor mone and its potential rolein breast cancer.Proc Amer Assoc Cancer Res,2006,47:804-805.
|
| [27] |
Polgar N,Fogelgren B.Lysyl oxidase interacts with hor mone placental lactogen and synergistically promotes breast epithelial cell proliferation and migration.J Biol Chem,2007,282:3262-3272.
|
| [28] |
Shieh TM,Lin SC,Liu CJ,et al.Association of expression aberrances and genetic poly morphisms of lysyl oxidase with areca-associated oral tumorigenesis.Clin Cancer Res,2007,13:4378-4385.
|
| [29] |
Jeay S,Pianetti S,Kagan HM,et al.Lysyl oxidase inhibits ras-mediated transfor mation by preventing activation of NF-kappa B.Mol Cell Biol,2003,23:2251-2263.
|
| [30] |
Giamprzzi M,Oleggin R,Di Donnto A,et al.Demonstration of in vitro interaction bet ween tumor suppressor lysyl oxidase and histones H1 and H2:definition of the regions involved.Biochi m Biophys Acta,2003,1647:245-251.
|